News
TipRanks on MSN1d
Dimerix Unveils Progress on Phase 3 Asset for Rare Kidney Disease
Dimerix Limited ( ($AU:DXB) ) has issued an announcement. Dimerix Limited has released an updated investor presentation and video detailing the ...
Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the best small cap stocks with biggest upside potential. On August 10, Citi ...
With a solid cash position and expected profitability by late 2026, Apellis stock is set for recovery. Read the latest ...
Data show that diabetes-associated metabolic issues lead to kidney lipid accumulation, resulting in inflammation and fibrosis that cause progressive kidney damage and disease progression.Earlier data ...
In a further positive sign the ASX healthcare sector may be recovering, Morgans' senior healthcare analyst Scott Power has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback